Product Information

ENTECAVIR 0.5 MG TABLET is a generic product labeled by Carlsbad Technology Inc., priced at $0.2460 per EA under NDC 61442031130. Its NADAC has been published 111 times since Oct 2, 2024.

FDA first approved this application on Nov 10, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENTECAVIR 0.5 MG TABLET

Entecavir
$0.2460per EA

Strength

.5 mg/1

NDC

61442031130

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ENTECAVIR

Approval Type

Generic (ANDA)

FDA Application

ANDA208195

FDA Approved

11/10/2021

TE Code

AB

On Market Since

11/10/2021

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for ENTECAVIR 0.5 MG TABLET has been published 111 times since Oct 2, 2024, and over the history we have for it it has declined 16.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2460 per EA
All-time high$0.3429 (Nov 13, 2024)
All-time low$0.2096 (May 20, 2026)
52-week high$0.2460
52-week low$0.2096
Median price$0.2457
Average price$0.2515
Largest weekly change-28.3% (Nov 20, 2024)
Weeks tracked111
Tracking sinceOct 2, 2024

Price History

1W

0.0%

1M

+12.5%

3M

+15.4%

6M

+17.4%

1Y

+1.8%

3Y

N/A

5Y

N/A

All

-16.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ENTECAVIR 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 0.5 MG TABLET, manufactured by Carlsbad Technology Inc., is $0.2460 per EA (NDC 61442031130), effective Nov 11, 2026.

How has the price of ENTECAVIR 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ENTECAVIR 0.5 MG TABLET has declined 16.5%. It has been tracked across 111 weekly CMS publications since Oct 2, 2024.

What are the highest and lowest recorded NADAC prices for ENTECAVIR 0.5 MG TABLET?

Since Oct 2, 2024, the NADAC for ENTECAVIR 0.5 MG TABLET has ranged from a low of $0.2096 (May 20, 2026) to a high of $0.3429 (Nov 13, 2024), with a median of $0.2457 per EA.

Are there cheaper alternatives to ENTECAVIR 0.5 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENTECAVIR 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ENTECAVIR 0.5 MG TABLET?

ENTECAVIR 0.5 MG TABLET (NDC 61442031130) is labeled by Carlsbad Technology Inc., and CMS classifies it as a generic product.